BR112015003328A2 - ciclopentilpirazóis como bloqueadores de canal de cálcio de tipo-n - Google Patents
ciclopentilpirazóis como bloqueadores de canal de cálcio de tipo-nInfo
- Publication number
- BR112015003328A2 BR112015003328A2 BR112015003328A BR112015003328A BR112015003328A2 BR 112015003328 A2 BR112015003328 A2 BR 112015003328A2 BR 112015003328 A BR112015003328 A BR 112015003328A BR 112015003328 A BR112015003328 A BR 112015003328A BR 112015003328 A2 BR112015003328 A2 BR 112015003328A2
- Authority
- BR
- Brazil
- Prior art keywords
- cyclopentylpyrazoles
- compounds
- calcium channel
- channel blockers
- type calcium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
abstract disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. such compounds are represented by formula (i) as follows: formula (i) wherein r1, r2 , r3 , q , and g are defined herein. __________________________________________ tradução do resumo resumo patente de invenção: "ciclopentilpirazóis como bloquea-dores de canal de cálcio de tipo-n". a presente invenção refere-se aos compostos, às compo-sições e aos métodos para o tratamento de várias doenças, síndro-mes, condições e distúrbios, incluindo dor. tais compostos são repre-sentados pela fórmula (i) a seguir, fórmula (i) em que r1, r2, r3, q, e g são aqui definidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261683775P | 2012-08-16 | 2012-08-16 | |
PCT/US2013/055267 WO2014028801A1 (en) | 2012-08-16 | 2013-08-16 | Cyclopentylpyrazoles as n-type calcium channel blockers |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015003328A2 true BR112015003328A2 (pt) | 2017-07-04 |
Family
ID=49036654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015003328A BR112015003328A2 (pt) | 2012-08-16 | 2013-08-16 | ciclopentilpirazóis como bloqueadores de canal de cálcio de tipo-n |
Country Status (21)
Country | Link |
---|---|
US (1) | US8853418B2 (pt) |
EP (1) | EP2885279A1 (pt) |
JP (1) | JP6262231B2 (pt) |
KR (1) | KR20150042270A (pt) |
CN (1) | CN105189464B (pt) |
AU (1) | AU2013302469B2 (pt) |
BR (1) | BR112015003328A2 (pt) |
CA (1) | CA2882042A1 (pt) |
CL (1) | CL2015000357A1 (pt) |
CR (1) | CR20150068A (pt) |
EA (1) | EA201590382A1 (pt) |
EC (1) | ECSP15009830A (pt) |
HK (1) | HK1217690A1 (pt) |
IL (1) | IL237189A0 (pt) |
IN (1) | IN2015DN01237A (pt) |
MX (1) | MX2015002037A (pt) |
PE (1) | PE20151137A1 (pt) |
PH (1) | PH12015500314A1 (pt) |
SG (1) | SG11201501140RA (pt) |
WO (1) | WO2014028801A1 (pt) |
ZA (1) | ZA201501746B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9434693B2 (en) | 2012-08-16 | 2016-09-06 | Janssen Pharmaceutica Nv | Substituted pyrazoles as N-type calcium channel blockers |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
EP2957559A1 (en) * | 2014-06-18 | 2015-12-23 | L'Universite de Strasbourg | Iminosydnone derivatives for conjugation and release of compounds of interest |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1287174B1 (it) * | 1996-11-15 | 1998-08-04 | Angelini Ricerche Spa | Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono |
JP2001220390A (ja) * | 2000-02-09 | 2001-08-14 | Yamanouchi Pharmaceut Co Ltd | 縮合ピラゾール誘導体 |
CN1938023A (zh) * | 2004-03-08 | 2007-03-28 | 惠氏公司 | 离子通道调节剂 |
WO2005087747A1 (en) * | 2004-03-08 | 2005-09-22 | Wyeth | Ion channel modulators |
CN101304975A (zh) * | 2005-11-09 | 2008-11-12 | 艾博特公司 | P2x7受体拮抗剂及其用途 |
-
2013
- 2013-08-16 KR KR20157006348A patent/KR20150042270A/ko not_active Application Discontinuation
- 2013-08-16 JP JP2015527651A patent/JP6262231B2/ja not_active Expired - Fee Related
- 2013-08-16 PE PE2015000205A patent/PE20151137A1/es not_active Application Discontinuation
- 2013-08-16 US US13/968,470 patent/US8853418B2/en active Active
- 2013-08-16 AU AU2013302469A patent/AU2013302469B2/en not_active Ceased
- 2013-08-16 WO PCT/US2013/055267 patent/WO2014028801A1/en active Application Filing
- 2013-08-16 CA CA2882042A patent/CA2882042A1/en not_active Abandoned
- 2013-08-16 SG SG11201501140RA patent/SG11201501140RA/en unknown
- 2013-08-16 MX MX2015002037A patent/MX2015002037A/es not_active Application Discontinuation
- 2013-08-16 BR BR112015003328A patent/BR112015003328A2/pt not_active IP Right Cessation
- 2013-08-16 EA EA201590382A patent/EA201590382A1/ru unknown
- 2013-08-16 CN CN201380054099.7A patent/CN105189464B/zh not_active Expired - Fee Related
- 2013-08-16 EP EP13753390.7A patent/EP2885279A1/en not_active Withdrawn
-
2015
- 2015-02-10 CR CR20150068A patent/CR20150068A/es unknown
- 2015-02-11 IL IL237189A patent/IL237189A0/en unknown
- 2015-02-13 PH PH12015500314A patent/PH12015500314A1/en unknown
- 2015-02-16 CL CL2015000357A patent/CL2015000357A1/es unknown
- 2015-02-16 IN IN1237DEN2015 patent/IN2015DN01237A/en unknown
- 2015-03-13 EC ECIEPI20159830A patent/ECSP15009830A/es unknown
- 2015-03-13 ZA ZA2015/01746A patent/ZA201501746B/en unknown
-
2016
- 2016-05-05 HK HK16105125.9A patent/HK1217690A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2882042A1 (en) | 2014-02-20 |
IL237189A0 (en) | 2015-04-30 |
IN2015DN01237A (pt) | 2015-06-26 |
JP2015524851A (ja) | 2015-08-27 |
PE20151137A1 (es) | 2015-08-07 |
JP6262231B2 (ja) | 2018-01-17 |
PH12015500314A1 (en) | 2015-03-30 |
CL2015000357A1 (es) | 2015-06-12 |
SG11201501140RA (en) | 2015-04-29 |
HK1217690A1 (zh) | 2017-01-20 |
US20140051660A1 (en) | 2014-02-20 |
EA201590382A1 (ru) | 2015-08-31 |
US8853418B2 (en) | 2014-10-07 |
AU2013302469A1 (en) | 2015-02-26 |
ZA201501746B (en) | 2017-08-30 |
EP2885279A1 (en) | 2015-06-24 |
CR20150068A (es) | 2015-04-30 |
CN105189464B (zh) | 2017-12-12 |
WO2014028801A1 (en) | 2014-02-20 |
CN105189464A (zh) | 2015-12-23 |
KR20150042270A (ko) | 2015-04-20 |
ECSP15009830A (es) | 2015-12-31 |
MX2015002037A (es) | 2016-01-22 |
AU2013302469B2 (en) | 2017-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015003393A2 (pt) | pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n | |
BR112012010253A2 (pt) | compostos de pirimidina como moduladores do receptor delta opioide | |
BR112013005141A2 (pt) | diazetidinil diamida como inibidores de monoacilglicerol lipase | |
BR112015003359A2 (pt) | pirrolopirazóis como bloqueadores de canal de cálcio de tipo-n | |
BR112014013526A8 (pt) | conjugados de anticorpo-fármaco e compostos, composições e métodos relacionados | |
BR112017006809A2 (pt) | compostos de ácido carboxílico úteis para inibir a prostaglandina e2 sintase-1 microssômica | |
CY1118678T1 (el) | Παραγωγα καρβοξαμιδιου χλωρο-πυραζινης χρησιμα για την θεραπευτικη αντιμετωπιση ασθενειων που ευνοουνται απο την ανεπαρκη ενυδατωση του βλεννογονου | |
BR112013023028A2 (pt) | composto da fórmula, composição farmacêutica e formulação farmacêutica tópica | |
MD4496B1 (ro) | Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral | |
GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
ECSP12011815A (es) | Métodos sintéticos para compuestos espiro-oxoindol | |
BR112013007287A2 (pt) | amidas oxopiperazina-azetidina e amidas oxodiazepina-azetina como inibidores de monoacilglicerol lipase | |
BR112015003395A2 (pt) | pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n | |
PH12014502413A1 (en) | Cyclic bridgehead ether dgat1 inhibitors | |
MX2016007128A (es) | Compuestos del receptor 6 de quimiocina (ccr6). | |
BR112017007014A2 (pt) | derivados de benzotiofenila substituídos como agonistas do gpr40 para o tratamento de diabetes tipo ii | |
MX2016001855A (es) | Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio. | |
IN2012DN03846A (pt) | ||
BR112013003121A2 (pt) | moduladores de trpv3 | |
BR112015003328A2 (pt) | ciclopentilpirazóis como bloqueadores de canal de cálcio de tipo-n | |
EA201591449A1 (ru) | Способы получения противораковых композиций | |
MX2016002043A (es) | Imidazoles sustituidos como bloqueadores de canales de calcio tipo n. | |
CR20130005A (es) | Agentes terapéuticos 976 | |
MX2015007460A (es) | Agentes para el tratamiento del dolor y usos de los mismos. | |
MX2016001858A (es) | Aza-oxo-indoles novedosos para el tratamiento y profilaxis de la infeccion por el virus sincicial respiratorio. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |